Medvarsity Logo
Thumbnail for Postoperative Pulmonary Complications

CASE DISCUSSION

Postoperative Pulmonary Complications

United Arab Emirates flagPresented United Arab Emirates by Dr. Prashant Nasa

Views

0

Case Description

Postoperative pulmonary complications are a significant cause of morbidity, prolonged hospital stays, and delayed recovery following surgery. This session will explore common complications, including atelectasis, pneumonia, aspiration, and respiratory failure, along with their risk factors and...

Case Summary

  • Postoperative pulmonary complications represent a critical composite outcome encompassing diverse respiratory abnormalities, including atelectasis, pneumonia, acute respiratory distress syndrome, and aspiration pneumonitis. Arising from surgical insult, positioning, and general anesthesia, these complications occur in five to thirty percent of surgical cases, surpassing perioperative cardiac events in both frequency and clinical impact. Crucially, developing a single postoperative pulmonary complication increases short- and long-term mortality ten- to fifteen-fold, with adverse prognostic effects persisting up to five years. While historical definitions relied on regional expert consensus, evolving global Delphi frameworks are establishing standardized severity criteria and explicit surveillance windows to improve research validity and bedside utility.

Speaker Profile

Dr. Prashant Nasa

Dr. Prashant Nasa

European Diploma in Intensive Care
Prashant Nasa is an experienced Intensivist, Anaesthesiologist, and researcher with expertise in critical care medicine and fluid management in critically ill patients. He is actively involved in academic research, international critical care collaborations, and evidence-based clinical practice. Dr. Nasa also serves as an editor and contributes extensively to advancing critical care education globally.

Disclosures

Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.